Beware, iPhone users: First-ever iOS GoldDigger trojan can steal face ID and bank accounts

Deutschland Nachrichten Nachrichten

Beware, iPhone users: First-ever iOS GoldDigger trojan can steal face ID and bank accounts
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 PhoneArena
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 59%

Tsveta, a passionate technology enthusiast and accomplished playwright, combines her love for mobile technologies and writing to explore and reveal the transformative power of tech.

because they think iPhones are more secure. But that might not be the case anymore because there is a new banking trojan out there that is specifically made to attack iPhone users.), the Android trojan GoldDigger has now been effectively adapted to target iPhone and iPad users. The company asserts that this might be the first trojan crafted for iOS, posing a significant threat by gathering facial recognition data, ID documents, and even SMS.

It is important to mention that right now, the GoldPickaxe trojan is focusing on victims in Vietnam and Thailand. Yet, as seen in other malware schemes, if this one hits the jackpot, the cybercriminals running it might broaden their reach to target both iPhone and Android users in the US, Europe, and the rest of the world.Android banking trojans are usually spread through dodgy apps and phishing schemes.

Given how profitable a banking trojan like GoldDigger or GoldPickaxe can be — especially when it can target iPhones as well as— this likely isn’t the last we will hear about this malware or the hackers behind it.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

PhoneArena /  🏆 322. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Andy Kim sinks first lady Tammy Murphy in NJ Senate race’s first Democratic conventionAndy Kim sinks first lady Tammy Murphy in NJ Senate race’s first Democratic conventionHis victory shows he can get support of the rank-and-file Democrats he'll need to overcome Tammy Murphy's advantages.
Weiterlesen »

Hot 100 First-Timers: BossMan Dlow Scores His First Chart Hit With ‘Get In With Me’Hot 100 First-Timers: BossMan Dlow Scores His First Chart Hit With ‘Get In With Me’BossMan Dlow debuts on the Hot 100 with 'Get In With Me.' Get the details.
Weiterlesen »

Mogul Memo to Byron Allen: Beware the Bidder Who Cried WolfMogul Memo to Byron Allen: Beware the Bidder Who Cried WolfAllen's quest for Paramount casts a harsh light on the entrepreneur’s constant offers, murky financing and focus on linear assets
Weiterlesen »

Stock futures are little changed after Dow tops 38,000 for the first time: Live updatesStock futures are little changed after Dow tops 38,000 for the first time: Live updatesWall Street is coming off a notable trading session for the major averages, with the Dow Jones Industrial Average hitting 38,000 for the first time ever.
Weiterlesen »

First-Ever CRISPR-Based Therapy Approved for Sickle Cell DiseaseFirst-Ever CRISPR-Based Therapy Approved for Sickle Cell DiseaseU.S. patients with sickle cell disease now have a novel treatment option: the first-ever CRISPR-based therapy.for use in patients age 12 years and older. In addition to offering hope of relief for people with severe forms of the painful blood disorder, the treatment, called Casgevy, is the world’s first to genetically tweak cells using theAnother gene therapy for sickle cell disease, called Lyfgenia and developed by biotech company bluebird bio, based in Somerville, Mass., was also approved December 8. Getting a green light for the first CRISPR-based medicine is exciting, says David Altshuler, chief scientific officer at Boston-based Vertex Pharmaceuticals, which developed the drug in a joint venture with CRISPR Therapeutics, a company in Cambridge, Mass. But the fact that the drug fills an unmet need for underserved patients is “more compelling to me, personally, than the fact that it’s CRISPR.” , most of them Black or Latino, have sickle cell disease. It is caused by a genetic defect in hemoglobin, the oxygen-carrying protein in red blood cells
Weiterlesen »

CBS New York Book Club's First Readers' Choice for 2024CBS New York Book Club's First Readers' Choice for 2024CBS New York readers have chosen 'Where You End' by Abbott Kahler as the first Readers' Choice for 2024. The book is about a woman with amnesia who uncovers her dangerous past with the help of her identical twin. Join the Book Club to read along and discuss.
Weiterlesen »



Render Time: 2025-02-25 12:32:12